The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease
Abstract
Interleukin-1β (IL-1β ) is known to have a number of effects on the different cell types present within coronary arteries. In this study we identified the location and phenotype of cells containing IL-1β in human coronary artery specimens from patients suffering from either coronary atherosclerosis or cardiomyopathy and correlated the presence of IL-1β with disease severity. Luminal endothelial cells, adventitial vessel wall cells, and macrophages were double labeled immunohistochemically for IL-1β protein and a cell type–specific monoclonal antibody for either endothelial cells or macrophages. In situ hybridization was performed to locate the presence of IL-1β mRNA within the coronary artery wall. In this study IL-1β protein was found to be increased in the adventitial vessel walls of atherosclerotic coronary arteries compared with coronary arteries from nonischemic cardiomyopathic hearts. This increase was directly proportional to the severity of coronary atherosclerosis. IL-1β protein was also detected in luminal endothelium and macrophages of atherosclerotic coronary arteries and coronary arteries from nonischemic cardiomyopathic hearts. IL-1β mRNA was found in luminal endothelial cells, adventitial vessel endothelial cells, and macrophages. We conclude that IL-1β is produced by endothelial cells and macrophages in coronary arteries from ischemic hearts and to a lesser extent from nonischemic cardiomyopathic hearts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712
Quantitation of mRNA by the polymerase chain reaction.
Wang, A. M., Doyle, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,625
Dinarello, C. A. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277884 · Cited by 1,532
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables
Mehta, C. R., & Patel, N. R. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477989 · Cited by 898
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Glauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Localization of PDGF-B Protein in Macrophages in All Phases of Atherogenesis
Ross, R., Masuda, J., Raines, E. W., Gown, A. M., Katsuda, S., Sasahara, M., Malden, L. T., Masuko, H., & Sato, H. (1990) · Science · doi:10.1126/science.2343305 · Cited by 574
Libby, P., Warner, S. J., & Friedman, G. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113346 · Cited by 533
Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed · Cited by 377
Schleimer, R. P., & Rutledge, B. K. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.2.649 · Cited by 355
Interleukin 1: the first interleukin
di Giovine, F. S., & Duff, G. W. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90005-t · Cited by 338
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
Nachman, R. L., Hajjar, K. A., Silverstein, R. L., & Dinarello, C. A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1595 · Cited by 316
Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers.
Cavender, D. E., Haskard, D. O., Joseph, B., & Ziff, M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.1.203 · Cited by 294
Thomas, K. A., Rios-Candelore, M., Giménez-Gallego, G., DiSalvo, J., Bennett, C., Rodkey, J., & Fitzpatrick, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6409 · Cited by 286
Warner, S. J. C., Auger, K. R., & Libby, P. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1911 · Cited by 279
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.
Libby, P., Ordovas, J. M., Birinyi, L. K., Auger, K. R., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112732 · Cited by 258
Edelman, E. R., Nugent, M. A., Smith, L. T., & Karnovsky, M. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115607 · Cited by 245
Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.
Moyer, C. F., Sajuthi, D., Tulli, H. M., & Williams, J. K. (1991) · PubMed Central · Cited by 234
Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
Beutler, B. A., & Cerami, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.6.3969 · Cited by 232
Self-regulation of procoagulant events on the endothelial cell surface.
Stern, D. M., Bank, I., Nawroth, P. P., Cassimeris, J., Kisiel, W., Fenton, J. W., Dinarello, C., Chess, L., & Jaffe, E. A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.4.1223 · Cited by 223
Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.
Warner, S. J., Auger, K. R., & Libby, P. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.5.1316 · Cited by 222
Immunohistochemical study of intimal microvessels in coronary atherosclerosis.
Zhang, Y., Cliff, W. J., Schoefl, G. I., & Higgins, G. (1993) · PubMed Central · Cited by 200
Cytokines and growth factors in atherogenesis.
Clinton, S. K., & Libby, P. (1992) · PubMed · Cited by 199
Interleukin 1 is an autocrine regulator of human endothelial cell growth.
Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D., & Stern, D. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6487 · Cited by 198
Tipping, P. G., & Hancock, W. W. (1993) · PubMed · Cited by 184
IL-1 and IFN-gamma increase vascular permeability.
Martin, S., Maruta, K., Burkart, V., Gillis, S. A., & Kolb, H. (1988) · PubMed Central · Cited by 136
Interleukin 1 inhibits contraction of vascular smooth muscle.
Beasley, D., Cohen, R. A., & Levinsky, N. G. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113879 · Cited by 127
Montesano, R., Mossaz, A., Ryser, J. E., Orci, L., & VASSALLI, P. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.99.5.1706 · Cited by 101
Modalities for reducing interleukin 1 activity in disease
Dinarello, C. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90042-j · Cited by 90
Lipoproteins increase growth of mitogen‐stimulated arterial smooth muscle cells
Libby, P., Miao, P., Ordovás, J. M., & Schaefer, E. J. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041240102 · Cited by 86
Gay, C. G., & Winkles, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.296 · Cited by 74
Libby, P., Wyler, D. J., Janicka, M., & Dinarello, C. A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.2.186 · Cited by 59
RASMUSSEN, L. ‐., & Seljelid, R. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01147.x · Cited by 25
Modalities for reducing interleukin 1 activity in disease
Dinarello, C. A. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90200-4 · Cited by 23
Cited by
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Abderrazak, A., Syrovets, T., Couchie, D., El Hadri, K., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 732
Metadata
- Authors
- Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., & Holt, C. M.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1996-08
- Volume
- 16
- Issue
- 8
- Pages
- 1000-1006
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W1973351162
- Cited by
- 310
- References
- 40
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.